Theralink® Technologies Announces New PLA Code and Information Submittal to Medicare Contractors for the Theralink Assay for Advanced Breast Cancer Patients

Corporate Breaking News

Home : Theralink® Technologies Announces New PLA Code and Information Submittal to Medicare Contractors for the Theralink Assay for Advanced Breast Cancer Patients

Mar 21 2022	Theralink® Technologies Announces New PLA Code and Information Submittal to Medicare Contractors for the Theralink Assay for Advanced Breast Cancer Patients
DENVER, March 21, 2022 /PRNewswire/ -- Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), a precision medicine company with a patented, novel phosphoprotein-based assay for breast cancer today announced that the American Medical Association (AMA) has recently issued a new,...


Source:https://www.prnewswire.com:443/news-releases/theralink-technologies-announces-new-pla-code-and-information-submittal-to-medicare-contractors-for-the-theralink-assay-for-advanced-breast-cancer-patients-301506384.html

Related News
» Outlook on the Call Center AI Global Market to 2027 - Featuring Artificial Solutions International, Rulai and Pypestream Among Others » Foley Catheters Market size worth $ 1.78 Billion, Globally, by 2028 at 6.1% CAGR: Verified Market Research®